Escalon Medical Corp. (OTCMKTS:ESMC – Get Free Report) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.19 and traded as high as $0.21. Escalon Medical shares last traded at $0.21, with a volume of 7,500 shares.
Escalon Medical Trading Down 1.2%
The company has a market cap of $1.56 million, a price-to-earnings ratio of 1.91 and a beta of 0.11. The firm has a 50-day moving average price of $0.19 and a 200 day moving average price of $0.18. The company has a current ratio of 2.59, a quick ratio of 1.06 and a debt-to-equity ratio of 0.04.
Escalon Medical (OTCMKTS:ESMC – Get Free Report) last issued its earnings results on Friday, May 15th. The medical equipment provider reported $0.16 EPS for the quarter. The company had revenue of $2.61 million during the quarter. Escalon Medical had a negative return on equity of 21.42% and a net margin of 16.17%.
Escalon Medical Company Profile
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea.
See Also
- Five stocks we like better than Escalon Medical
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
